Business
CSL (ASX:CSL) share price heads lower on haemophilia B deal
The CSL Limited (ASX: CSL) share price is slightly lower today despite announcing plans to buy rights for novel late-stage gene therapy candidate.
In late afternoon trade, the global biotech’s shares are swapping hands for $276.06, down 0.5%.
What did CSL announce?
Investors appear…
Continue Reading
-
Noosa News22 hours agoWhere was Australia’s new opposition leader born? Take the Brisbane Times Quiz
-
Noosa News12 hours agoWoman charged after alleged hoax bomb threats to four Bayside childcare centres and a primary school in Brisbane
-
General22 hours agoAlbanese calls for deeper economic ties with Indonesia on first visit since re-election
-
General18 hours agoCyber attack, data breach hits fashion giant Dior